VB
The startup produces assays and test kits for drug screening, pathogen detection, and cancer research, utilizing proprietary DNA-modifying enzymes that enable laboratories to leverage existing instruments without the need for staff retraining. This approach reduces operational costs and enhances efficiency in research settings by streamlining testing processes.
Updated 3 months ago
Funding
$3.1M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Funding rounds are not available yet.
Founders
Product
Features
- The startup produces assays and test kits for drug screening, pathogen detection, and cancer research, utilizing proprietary DNA-modifying enzymes that enable laboratories to leverage existing instruments without the need for staff retraining. This approach reduces operational costs and enhances efficiency in research settings by streamlining testing processes.